Shifting Paradigms in Lung Cancer
15th Nov 2005, 03:05 GMT
This editorial notes that, ironically, adjuvant therapies are often tested and developed in patients with advanced disease, where lasting clinical benefit is rarely observed. Nature Clinical Practice Oncology
Shifting Paradigms in Lung Cancer related news:
- Lung cancer attacks along sex lines, particularly attacking women — The Cancer Blog
- Lung Cancer Caring Ambassadors Program: Lung Cancer Caring Ambassadors Program Commemorates Lung Cancer Awareness Month With Atlanta Run & Walk — Market Wire - Medical and Healthcare
- Tobacco related lung cancer gets help from plant — The Cancer Blog
- Researchers uncover cellular clues to vitamin A resistance in lung cancer — EurekAlert! - Breaking News
- Lung cancer, newly identified protein may one day help improve treatment — Medical News Today RSS/XML Feed
- Lung Cancer Q & A — MedicineNet Smoker's Lung: Pathology Photo Essay Specialty
- Researchers uncover clues to vitamin A resistance in lung cancer — EurekAlert! - Breaking News
- Women more prone to lung cancer — United Press International - NewsTrack
- Clinical trial prompts call for national screening for lung cancer — The Irish Times' Health Top Stories
- New antibody profiling technique to test for lung cancer — EurekAlert! - Breaking News
Latest news from Medscape Headlines:
- New Treatment for Ischemic Stroke on the Horizon
- Adding Bevacizumab to First-Line Lung Cancer Therapy Shows Potential
- Type 1 and 2 T Helper Cell-mediated Colitis
- Radiation Therapy for Chronic Vesicular Hand Dermatitis
- November 14, 2006: In the News
- Alcoholic Liver Disease-Pathophysiological Aspects and Risk Factors
- Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet
- Bleeding-Edge Benefits
- End-Stage Renal Disease and Drug-Eluting Stents: One Small Step Forward?
- November 13, 2006: In the News